DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI)
Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients’ needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments for neglected patients.
DRUGS FOR NEGLECTED DISEASES INITIATIVE (DNDI)
Industry:
Biotechnology Medical Non Profit
Founded:
2003-01-01
Address:
Geneva, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.dndi.org
Total Employee:
101+
Status:
Active
Contact:
+41 22 906 9230
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Investors List
la Caixa
la Caixa investment in Grant - Drugs for Neglected Diseases initiative (DNDi)
Official Site Inspections
http://www.dndi.org Semrush global rank: 1.63 M Semrush visits lastest month: 15.37 K
- Host name: od-98eb18.infomaniak.ch
- IP address: 195.15.209.226
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Drugs for Neglected Diseases initiative (DNDi)"
About DNDi - Drugs for Neglected Diseases initiative (DNDi)
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients …See details»
Who we are | DNDi
In 2003, the Indian Council of Medical Research (ICMR), the Oswaldo Cruz Foundation in Brazil, the Kenyan Medical Research Institute (KEMRI), the …See details»
Drugs for Neglected Diseases Initiative - Wikipedia
The logo of the Drugs for Neglected Diseases initiative (DNDi) The Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients' needs-driven, non-profit drug research and …See details»
DNDi North America
DNDi puts patients – not profits – at the heart of R&D. ... In 2003, DNDi was founded by MSF, the World Health Organization, Institut Pasteur, the Indian Council of Medical Research, the …See details»
About | DNDi North America - dndina.org
DNDi has built a team of more than 240 employees working across eight offices. DNDi North America, created in 2008 and based in New York City, is a registered 501(c)(3) non-profit …See details»
Drugs for Neglected Diseases initiative (DNDi) - LinkedIn
The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients ...See details»
DNDi
DNDi was founded in 2003 by Doctors Without Borders/Médecins Sans Frontières (MSF), the Institut Pasteur, the Kenya Medical Research Institute, the Oswaldo Cruz Foundation in Brazil, …See details»
Our story: 20 years of DNDi
Browse through the timeline of DNDi's first 20 years. ... Malaysia (Ministry of Health), and France (Institut Pasteur) come together to create DNDi as a non-profit organization that develops …See details»
Drugs for Neglected Diseases initiative (DNDi) - Research!America
The Drugs for Neglected Diseases initiative (DNDi) is a not-for-profit medical research organization that discovers, develops, and delivers safe, effective, and affordable treatments …See details»
Drugs for Neglected Diseases Initiative - DNDi
DNDi "Drugs for Neglected Diseases initiative" is a not-for-profit research and development organization that discovers, develops, and delivers safe, effective, and affordable treatments for neglected patients. Since its creation in 2003, …See details»
Drugs for Neglected Diseases Initiative - WikiProjectMed
The Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patients' needs-driven, non-profit drug research and development (R&D) organization that is developing new treatments …See details»
DNDi - Drugs for Neglected Diseases Initiative - DevelopmentAid
Dec 6, 2024 The Drugs for Neglected Diseases initiative (DNDi) is a collaborative, patient-needs driven, not-for-profit research and development (R&D) organization that develops safe, …See details»
Partners: Non-profit organizations, NGOs, and networks | DNDi
Today, DNDi has forged a diverse range of alliances and research collaborations with over 200 partners and service providers in nearly 50 countries. Industry partners and service providers …See details»
Drug discovery explained - Episode 3 - stories.dndi.org
DNDi researchers explains this important drug development phase during which scientists ‘play LEGO in the lab’ by tweaking molecules until they meet the high standards required for the …See details»
DNDi - GlobalCharityJobs
Established in 2003 Drugs for Neglected Diseases initiative (DNDi) is a not-for-profit research and development (R&D) organization that develops new, improved, and affordable medicines for …See details»
How we work | DNDi
Feb 13, 2025 This approach has enabled DNDi to work on better treatments for mycetoma, paediatric HIV, hepatitis C, and cryptococcal meningitis. It also allows us to contribute through …See details»
Drug Discovery Explained - stories.dndi.org
Photo credit: Xavier Vahed-DNDi, Swiss TPH, Fábio Nascimento-DNDi, Sydelle Willow Smith-DNDi The Drugs for Neglected Diseases initiative ( DNDi ) is an international non-profit …See details»
Strategy | DNDi
Powering our ambitions. We will maintain a diverse workforce and an inclusive culture, which are central to the success of DNDi’s mission and programmes.; We will adopt best practices in …See details»
DNDi supporting a pioneering project that integrates Indigenous ...
6 days ago Carried out in partnership with local leaders, the Organización Wiwa (Organización Wiwa Yugumaiun Bunkuanarrua Tayrona), the health organization Dusakawi IPSI, and the …See details»
New treatment for cryptococcal meningitis enters Phase II trial as ...
5 days ago A new, easier-to-administer and patient-friendly sustained-release formulation of flucytosine, a medicine used to treat cryptococcal meningitis, has entered Phase II clinical …See details»